Ocugen Inc. (NASDAQ: OCGN) started the day on May 25, 2023, with a price decrease of -3.73% at $0.45. During the day, the stock rose to $0.49 and sunk to $0.448 before settling in for the price of $0.47 at the close. Taking a more long-term approach, OCGN posted a 52-week range of $0.44-$3.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its Annual Earning per share during the time was 63.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -26.70%. This publicly-traded company’s shares outstanding now amounts to $225.52 million, simultaneously with a float of $215.47 million. The organization now has a market capitalization sitting at $99.37 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7734, while the 200-day Moving Average is $1.4061.
Ocugen Inc. (OCGN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Ocugen Inc.’s current insider ownership accounts for 0.40%, in contrast to 37.90% institutional ownership. According to the most recent insider trade that took place on Feb 16, this organization’s Chief Executive Officer sold 100,000 shares at the rate of 1.08, making the entire transaction reach 108,000 in total value, affecting insider ownership by 2,190,073. Preceding that transaction, on Jan 17, Company’s Chief Executive Officer sold 100,000 for 1.28, making the whole transaction’s value amount to 128,000. This particular insider is now the holder of 2,227,950 in total.
Ocugen Inc. (OCGN) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2023, the organization reported -$0.07 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.11) by $0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
Ocugen Inc.’s EPS decrease for this current 12-month fiscal period is -26.70% and is forecasted to reach -0.32 in the upcoming year.
Ocugen Inc. (NASDAQ: OCGN) Trading Performance Indicators
Let’s observe the current performance indicators for Ocugen Inc. (OCGN). It’s Quick Ratio in the last reported quarter now stands at 5.40. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, OCGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.36, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.32 at the market close of one year from today.
Technical Analysis of Ocugen Inc. (OCGN)
If we take a close look at the recent performances of Ocugen Inc. (NASDAQ: OCGN), its last 5-days Average volume was 17.06 million that shows progress from its year to date volume of 6.82 million. During the previous 9 days, stock’s Stochastic %D was recorded 23.34% While, its Average True Range was 0.0737.
Raw Stochastic average of Ocugen Inc. (OCGN) in the period of the previous 100 days is set at 0.76%, which indicates a major fall in contrast to 2.49% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 187.53% that was higher than 94.70% volatility it exhibited in the past 100-days period.
